|
911 |
Analysis of total cholesterol results measured in the initial period of the Croatian screening program for familial hypercholesterolemia: a pilot study
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 1: 215-224. 10 S.
|
|
|
|
912 |
An automatic chemiluminescence immunoassay for a novel biomarker NT-IGFBP-4: analytical performance and clinical relevance in heart failure
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 1: 205-214. 10 S.
|
|
|
|
913 |
Defining the analytical characteristics of a novel high-sensitivity point-of-care troponin I assay in its intended clinical environment
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 1: 194-204. 11 S.
|
|
|
|
914 |
Impact of renal and hepatic function on dihydropyrimidine dehydrogenase phenotype assessed by enzyme activity in peripheral blood mononuclear cells and uracilemia
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 1: 166-175. 10 S.
|
|
|
|
915 |
Not all anti-parietal cell antibody tests are equal for diagnosing pernicious anemia
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 1: 158-165. 08 S.
|
|
|
|
916 |
An isotope dilution-liquid chromatography-tandem mass spectrometry based candidate reference measurement procedure for the simultaneous quantification of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum and plasma
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 1: 133-146. 14 S.
|
|
|
|
917 |
Isotope dilution-liquid chromatography-tandem mass spectrometry-based candidate reference measurement procedures for the quantification of total and free phenytoin in human serum and plasma
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 1: 116-132. 17 S.
|
|
|
|
918 |
An isotope dilution-liquid chromatography-tandem mass spectrometry-based candidate reference measurement procedure for the quantification of 17β-estradiol in human serum and plasma
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 1: 97-115. 19 S.
|
|
|
|
919 |
Candidate reference measurement procedure based on isotope dilution-two dimensional-liquid chromatography-tandem mass spectrometry for the quantification of androstenedione in human serum and plasma
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 1: 83-96. 14 S.
|
|
|
|
920 |
An isotope dilution-liquid chromatography-tandem mass spectrometry-based candidate reference measurement procedure for the quantification of cortisone in human serum and plasma
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 1: 70-82. 13 S.
|
|
Administration
